Info

The OCD Stories

Welcome to The OCD Stories, hosted by Stuart Ralph. The podcast has been heard over 6 million times globally. Check out your first episode from our existing hundreds of episodes featuring experts, and people experiencing symptoms just like you today. If you do, you may just feel understood, heard and possibly help you identify your next step in your own personal journey to healing. Disclaimer - this podcast is not a replacement for therapy. Please seek treatment from a licensed mental health professional.
RSS Feed Subscribe in Apple Podcasts
The OCD Stories
2024
March
February
January


2023
December
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May
April
March
February
January


2015
December


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Aug 29, 2016

DISCLAIMER - This is an exploratory interview into the potential of psychedelics as a treatment for OCD. This is NOT a how to guide. If you take psychedelics, you do so at your own risk. 

In episode 35 of the podcast I chat with comedian Adam Strauss about his use of psychedelics as a potential treatment for OCD. We discuss the legality of it all and the future potential. Adam also shares the importance of acceptance and ACT.  Hope it helps.  

This podcast is also brought to you by nOCD: http://go.treatmyocd.com/theocdstories

To your success,

Stuart and The OCD Stories team

 

0 Comments
Adding comments is not available at this time.